Article Information
History
- July 2, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jacopo Polvere, MSc1,
- Massimiliano Fabbiani, MD3,
- Gabiria Pastore, PhD1,
- Ilaria Rancan, MD2,3,
- Barbara Rossetti, MD3,
- Miriam Durante, PhD2,
- Sara Zirpoli, MSc1,
- Enrico Morelli2,
- Elena Pettini, PhD1,
- Simone Lucchesi, PhD1,
- Fabio Fiorino, PhD1,
- Mario Tumbarello, MD2,3,
- Annalisa Ciabattini, PhD1,
- Francesca Montagnani, MD2,3,* and
- Donata Medaglini, PhD1,*
- 1Laboratory of Molecular Microbiology and Biotechnology, Department of Medical Biotechnologies, University of Siena; Siena, Italy
- 2Department of Medical Biotechnologies, University of Siena; Siena, Italy
- 3Department of Medical Sciences, Infectious and Tropical Diseases Unit, University Hospital of Siena; Siena, Italy
- ↵*Correspondence:
Donata Medaglini: donata.medaglini{at}unisi.it, +39 0577 233307, Francesca Montagnani: francesca.montagnani{at}unisi.it, +39 0577 586562
Posted July 02, 2022.
B cell response six months after SARS-CoV-2 mRNA vaccination in people living with HIV under antiretroviral therapy
